ITMI913324A1 - Composizione farmaceutica che comprende una particolare forma fisica di un derivato di un'ammide eterociclica - Google Patents

Composizione farmaceutica che comprende una particolare forma fisica di un derivato di un'ammide eterociclica

Info

Publication number
ITMI913324A1
ITMI913324A1 IT003324A ITMI913324A ITMI913324A1 IT MI913324 A1 ITMI913324 A1 IT MI913324A1 IT 003324 A IT003324 A IT 003324A IT MI913324 A ITMI913324 A IT MI913324A IT MI913324 A1 ITMI913324 A1 IT MI913324A1
Authority
IT
Italy
Prior art keywords
heterocyclic
starch
derivative
pharmaceutical composition
physical form
Prior art date
Application number
IT003324A
Other languages
English (en)
Inventor
Randy John Bradway
Arlene Clements
Ieuan John Edwards
James Joseph Holohan
Robert Josep Timko
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI913324(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB909027014A external-priority patent/GB9027014D0/en
Priority claimed from GB919115107A external-priority patent/GB9115107D0/en
Application filed by Ici Plc filed Critical Ici Plc
Publication of ITMI913324A0 publication Critical patent/ITMI913324A0/it
Publication of ITMI913324A1 publication Critical patent/ITMI913324A1/it
Application granted granted Critical
Publication of IT1256282B publication Critical patent/IT1256282B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ITMI913324A 1990-12-12 1991-12-11 Composizione farmaceutica che comprende una particolare forma fisica di un derivato di un'ammide eterociclica IT1256282B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027014A GB9027014D0 (en) 1990-12-12 1990-12-12 Pharmaceutical agents
GB919115107A GB9115107D0 (en) 1991-07-12 1991-07-12 Pharmaceutical agents

Publications (3)

Publication Number Publication Date
ITMI913324A0 ITMI913324A0 (it) 1991-12-11
ITMI913324A1 true ITMI913324A1 (it) 1993-06-11
IT1256282B IT1256282B (it) 1995-11-29

Family

ID=26298105

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI913324A IT1256282B (it) 1990-12-12 1991-12-11 Composizione farmaceutica che comprende una particolare forma fisica di un derivato di un'ammide eterociclica

Country Status (30)

Country Link
US (6) US5319097A (it)
EP (1) EP0490648B1 (it)
JP (1) JP2585495B2 (it)
KR (2) KR0183027B1 (it)
CN (2) CN1043405C (it)
AP (1) AP285A (it)
AT (1) ATE131048T1 (it)
AU (1) AU656157B2 (it)
BE (1) BE1004229A5 (it)
CA (2) CA2056066C (it)
CZ (1) CZ283181B6 (it)
DE (2) DE4140858A1 (it)
DK (1) DK0490648T3 (it)
ES (1) ES2079589T3 (it)
FI (1) FI101193B (it)
FR (1) FR2670488B1 (it)
GB (2) GB2251791B (it)
GR (1) GR3018318T3 (it)
HK (2) HK81597A (it)
HU (2) HU213211B (it)
IE (1) IE75348B1 (it)
IL (1) IL100091A (it)
IT (1) IT1256282B (it)
MX (1) MX9102473A (it)
MY (1) MY106315A (it)
NZ (1) NZ240939A (it)
PH (1) PH30928A (it)
RU (1) RU2106140C1 (it)
SK (2) SK279813B6 (it)
TW (1) TW276181B (it)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
DE9410461U1 (de) * 1994-07-01 1994-09-22 Merck Patent Gmbh, 64293 Darmstadt Mittel für die Röntgenfluoreszenzanalyse
US6279736B1 (en) 1995-04-19 2001-08-28 Capitol Specialty Plastics, Inc. Barrier pack having an absorbing agent applied to the interior of the pack
IN182496B (it) * 1996-02-20 1999-04-17 Reddy Research Foundation
US6630496B1 (en) 1996-08-26 2003-10-07 Genetics Institute Llc Inhibitors of phospholipase enzymes
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
GB9723985D0 (en) 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
US6828344B1 (en) 1998-02-25 2004-12-07 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6916841B2 (en) * 1998-02-25 2005-07-12 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6500853B1 (en) 1998-02-28 2002-12-31 Genetics Institute, Llc Inhibitors of phospholipase enzymes
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
KR100283682B1 (ko) * 1998-07-14 2001-03-02 조정래 열풍건조장치
US6253463B1 (en) 1999-04-26 2001-07-03 Niro A/S Method of spray drying
IN191496B (it) 1999-07-30 2003-12-06 Ranbaxy Lab Ltd
CA2382834A1 (en) * 1999-09-20 2001-03-29 Alza Corporation Process for lessening polymorphic conversion of a drug
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
IL140096A0 (en) * 2000-12-05 2002-02-10 Internat Specialty Products Is Process for preparation of zafirlukast
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
AU2002247019C1 (en) * 2001-01-26 2017-05-11 Organon Llc Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
JP2005502628A (ja) * 2001-07-10 2005-01-27 ファルマシア・アンド・アップジョン・カンパニー 結晶性チアジンオキサゾリジノン
UA76483C2 (en) * 2001-08-15 2006-08-15 Upjohn Co Crystalline form of malic acid salt of n-|2-(diethylamino)ethyl|-5-|(5-fluoro -2--oxo-3n-indol-3-ylidene)methyl]-2,4- dimelhyl-1n-pyrrole-3-carboxamide (variants), a method for preparing and compositions thereof
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
WO2003026643A2 (en) * 2001-09-21 2003-04-03 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
ES2311806T3 (es) * 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
EP1601669B1 (en) * 2003-03-07 2008-12-24 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
ITMI20041032A1 (it) * 2004-05-24 2004-08-24 Neuroscienze S C A R L Compositi farmaceutici
EP1855651A4 (en) * 2005-03-03 2011-06-15 Elan Pharma Int Ltd NANOPARTICULAR COMPOSITIONS OF HETEROCYCLIC AMIDE DERIVATIVES
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
WO2009018280A2 (en) * 2007-07-30 2009-02-05 Auspex Pharamaceuticals, Inc. Substituted indoles
US20090149662A1 (en) * 2007-12-05 2009-06-11 Raghupathi Reddy Anumula Processes for preparing zafirlukast
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
JP2017503814A (ja) 2014-01-22 2017-02-02 タケダ ゲー・エム・ベー・ハーＴａｋｅｄａ ＧｍｂＨ 部分的コントロール状態の重症喘息またはコントロール不良状態の重症喘息のｐｄｅ４インヒビターを用いた（およびロイコトリエン調節薬と組み合わせて用いた）治療
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
US11872210B2 (en) 2017-01-30 2024-01-16 Western New England University Thiol isomerases inhibitors and use thereof
US10752585B2 (en) 2017-12-28 2020-08-25 Council Of Scientific & Industrial Research Process for the preparation of Zafirlukast and analogs thereof
US20220370401A1 (en) 2021-05-19 2022-11-24 Quercis Pharma AG Method for treating amyotrophic lateral sclerosis using quercetin-containing compositions
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives
GB9027018D0 (en) * 1990-12-12 1991-01-30 Ici Plc Heterocyclic compounds
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole)

Also Published As

Publication number Publication date
RU2106140C1 (ru) 1998-03-10
DE69115229D1 (de) 1996-01-18
AU8899491A (en) 1992-06-18
EP0490648B1 (en) 1995-12-06
KR970005014A (ko) 1997-01-29
FR2670488B1 (fr) 1994-01-28
FI101193B1 (fi) 1998-05-15
US6143775A (en) 2000-11-07
CN1062291A (zh) 1992-07-01
IE75348B1 (en) 1997-08-27
HU213211B (en) 1997-03-28
DE4140858A1 (de) 1992-06-17
KR100207802B1 (ko) 1999-07-15
FR2670488A1 (fr) 1992-06-19
BE1004229A5 (fr) 1992-10-13
US5319097A (en) 1994-06-07
CA2056066A1 (en) 1992-06-13
CS375691A3 (en) 1992-06-17
GB2280606B (en) 1995-05-17
US5612367A (en) 1997-03-18
GB2251791B (en) 1995-05-17
AP285A (en) 1993-09-23
MY106315A (en) 1995-04-29
US5482963A (en) 1996-01-09
JP2585495B2 (ja) 1997-02-26
ITMI913324A0 (it) 1991-12-11
FI915826A (fi) 1992-03-31
CA2319308C (en) 2001-08-21
KR0183027B1 (ko) 1999-05-01
PH30928A (en) 1997-12-23
HU913865D0 (en) 1992-02-28
CN1043405C (zh) 1999-05-19
GB9126354D0 (en) 1992-02-12
EP0490648A1 (en) 1992-06-17
DK0490648T3 (da) 1996-05-06
IL100091A (en) 1998-08-16
US5504216A (en) 1996-04-02
IT1256282B (it) 1995-11-29
ES2079589T3 (es) 1996-01-16
JPH04266824A (ja) 1992-09-22
GR3018318T3 (en) 1996-03-31
TW276181B (it) 1996-05-21
US5993859A (en) 1999-11-30
HU211126A9 (en) 1995-10-30
CA2056066C (en) 2002-04-02
AP9100340A0 (en) 1992-01-31
GB2280606A (en) 1995-02-08
IE914310A1 (en) 1992-06-17
IL100091A0 (en) 1992-08-18
FI915826A0 (fi) 1991-12-11
HUT61281A (en) 1992-12-28
HK81397A (en) 1997-06-27
NZ240939A (en) 1994-05-26
GB9418154D0 (en) 1994-10-26
HK81597A (en) 1997-06-27
FI101193B (fi) 1998-05-15
KR920011493A (ko) 1992-07-24
CA2319308A1 (en) 1992-06-13
CZ283181B6 (cs) 1998-01-14
AU656157B2 (en) 1995-01-27
CN1105705C (zh) 2003-04-16
ATE131048T1 (de) 1995-12-15
MX9102473A (es) 1992-06-01
DE69115229T2 (de) 1996-05-09
SK279813B6 (sk) 1999-04-13
CN1243827A (zh) 2000-02-09
GB2251791A (en) 1992-07-22
SK279814B6 (sk) 1999-04-13

Similar Documents

Publication Publication Date Title
ITMI913324A1 (it) Composizione farmaceutica che comprende una particolare forma fisica di un derivato di un'ammide eterociclica
DK0658161T3 (da) Substituerede thiazolidindionderivater
DE69224656D1 (de) Arzneimittel
ITBO910390A0 (it) Pacchetto di sigarette
DE69119329D1 (de) Actinonin-Derivate
FI925523A (fi) Hydroxi- och alkoxipyridinderivat
ITMI912182A1 (it) Composti eterociclici ad attivita' a ii antagonista
DE69125099D1 (de) Indolderivate
DK1199307T3 (da) Farmaceutisk aktive benzoquinazolinforbindelser
DK0538301T3 (da) HIV-inhiberende benzenacetamidderivater
DK0449079T3 (da) Hydantoinderivater
DE69329894D1 (de) Arylamidderivate
DE69130255D1 (de) Oxadolderivate
FI925435A (fi) Foerfarande foer beredning av en vattenloesning av natriumfoereningar
DK0472733T3 (da) Phenantrenderivater
NO954323D0 (no) Heterocykliske derivater
IT9068000A0 (it) Oggetti lavorati a maglia che determinano una ridotta sensazione di umidita'.
NO933170D0 (no) Heterocykliske forbindelser
MX9102186A (es) Derivados de aminodiol
DE69619680D1 (de) Heterocyclisch kondensierte thiazol-derivate
IS3743A7 (is) Ný notkun á 5-(2 klóró-1-hýdroxíetýl)-4-metýlþíasól
FI941681A0 (fi) Tioformamidijohdannaiset
FI953518A0 (fi) Uudet substituoidut tiosemikarbatsonijohdannaiset
FI932846A0 (fi) Heterocykliska pesticida foereningar
MC2252A1 (fr) Composes heterocycliques

Legal Events

Date Code Title Description
0001 Granted